Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation
ConclusionConcomitant use of rivaroxaban with AADs appears to be well tolerated, warranting further investigation into the apparent benefits of a reduced dose of rivaroxaban combined with dronedarone.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research
More News: Amiodarone | Atrial Fibrillation | Cardiology | Cardiovascular | Heart | Study | Taiwan Health | Thrombosis